Installed Building Products (NYSE:IBP) Delivers Strong Q2 CY2026 Numbers

Installed Building Products (NYSE:IBP) reported Q2 CY2026 revenue of $777.8 million, up 2.3% year on year, ahead of Wall Street expectations. Non-GAAP EPS was $2.91, 13.6% above consensus, though down from $2.95 a year earlier. Analysts expect revenue growth of about 2.3% and full-year EPS to fall 5.1% to $10.56.

Original reporting
Published Aug 6, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Installed Building Products (NYSE:IBP) Delivers Strong Q2 CY2026 Numbers — source image
Decision brief

The 30-second read

$IBPBullishMed
01

Why it matters

Q2 CY2026 results beat Wall Street on revenue and adjusted EPS, but the article also highlights operating margin compression and expects full-year EPS to decline over the next 12 months.

02

Market read

Traders can reassess near-term expectations after the earnings beat, while weighing the forward EPS contraction and margin softness described in the article.

03

What to watch

Share count shrank 9.8% and EPS still declined YoY in the quarter (adjusted EPS $2.91 vs $2.95), so the quality of the beat may rely on buybacks and expense control rather than accelerating underlying demand.

Relevance 7/10Novelty 7/10Timing: post-Q2 results, published pre-market/early afternoon Aug 6

Background

Installed Building Products is a building-products installation services company focused on insulation, waterproofing, and related products for residential and commercial construction.

Company-level read

Ticker impact

$IBPBullishMedium confidence
Context

Installed Building Products reported Q2 CY2026 revenue of $777.8M (+2.3% YoY) and non-GAAP EPS of $2.91, beating consensus.

Expected impact

Near-term bias modestly positive, with follow-through dependent on whether investors focus on the beat versus the softer outlook and margin decline.

Evidence & confidence

The article provides concrete beat metrics (revenue and adjusted EPS) plus forward EPS contraction (-5.1%) and a YoY operating margin decline (12.2%, down 1.1 pts). The stock is also described as flat immediately after results, suggesting limited immediate repricing.

Market effects

Read-through to home-building installation demand and margin resilience, given the company’s operating margin compression despite a revenue beat.

No specific regional demand or policy details provided in the article.

Limited global relevance; the story is primarily US residential and commercial construction installation.

Counterpoint

The revenue beat may be cyclical noise, since the article flags slowing demand (two-year annualized revenue growth 1.8%) and operating margin down YoY.

Key entities

  • Installed Building Products

    Reported Q2 CY2026 revenue $777.8M (+2.3% YoY) and non-GAAP EPS $2.91, beating consensus; operating margin 12.2% down YoY; forward EPS expected to shrink -5.1%.

Related articles

$IBPMed

Installed Building Products, Inc. (IBP): Results of Operations and Financial Condition

Installed Building Products, Inc. (IBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ibp-q22026earningsrelease.htm EX-99.1 Document INSTALLED BUILDING PRODUCTS REPORTS SECOND QUARTER 2026 RESULTS; DECLARES REGULAR QUARTERLY CASH DIVIDEND Columbus, Ohio, August 6, 2026, Installed Building Products, Inc. (the "Company" or "IBP") (NYSE: IBP), an industry-l

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.